240 related articles for article (PubMed ID: 9290705)
61. A translocation t(6;14) in two cases of leiomyosarcoma: Molecular cytogenetic and array-based comparative genomic hybridization characterization.
de Graaff MA; de Jong D; Briaire-de Bruijn IH; Hogendoorn PC; Bovée JV; Szuhai K
Cancer Genet; 2015 Nov; 208(11):537-44. PubMed ID: 26361850
[TBL] [Abstract][Full Text] [Related]
62. Case Report: A Low-grade Uterine Leiomyosarcoma Showing Multiple Genetic Aberrations Including a Bi-allelic Loss of the Retinoblastoma Gene Locus, as well as Germ-line Uniparental Disomy for Part of the Long Arm of Chromosome 22.
Holzmann C; Koczan D; Loening T; Rommel B; Bullerdiek J
Anticancer Res; 2017 May; 37(5):2233-2237. PubMed ID: 28476787
[TBL] [Abstract][Full Text] [Related]
63. Two discrete regions of deletion at 7q in uterine leiomyomas.
Ishwad CS; Ferrell RE; Hanley K; Davare J; Meloni AM; Sandberg AA; Surti U
Genes Chromosomes Cancer; 1997 Jul; 19(3):156-60. PubMed ID: 9218996
[TBL] [Abstract][Full Text] [Related]
64. Subgroups of uterine leiomyomas based on cytogenetic analysis.
Hu J; Surti U
Hum Pathol; 1991 Oct; 22(10):1009-16. PubMed ID: 1842373
[TBL] [Abstract][Full Text] [Related]
65. Uterine leiomyomas: cytogenetic and histologic profile.
Meloni AM; Surti U; Contento AM; Davare J; Sandberg AA
Obstet Gynecol; 1992 Aug; 80(2):209-17. PubMed ID: 1635734
[TBL] [Abstract][Full Text] [Related]
66. Chromosome aberrations and expression of ras and myc oncogenes in leiomyomas and a leiomyosarcoma of the uterus.
Fotiou SK; Tserkezoglou AJ; Mahera H; Konstandinidou AE; Agnantis NJ; Pandis N; Bardi G
Eur J Gynaecol Oncol; 1992; 13(4):340-5. PubMed ID: 1516585
[TBL] [Abstract][Full Text] [Related]
67. Patterns of Chromosomal Abnormalities that Can Improve Diagnosis of Uterine Smooth Muscle Tumors.
Holzmann C; Markowski DN; VON Leffern I; Löning T; Bullerdiek J
Anticancer Res; 2015 Dec; 35(12):6445-56. PubMed ID: 26637855
[TBL] [Abstract][Full Text] [Related]
68. Integrated histologic and molecular analysis of uterine leiomyosarcoma and 2 benign variants with nuclear atypia.
Gao T; Finkelman BS; Ban Y; Li Y; Yin P; Bulun SE; Lu X; Ha C; Wei JJ
Cancer Sci; 2021 May; 112(5):2046-2059. PubMed ID: 33338329
[TBL] [Abstract][Full Text] [Related]
69. Biomarker resolution of uterine smooth muscle tumor necrosis as benign vs malignant.
Yang EJ; Mutter GL
Mod Pathol; 2015 Jun; 28(6):830-5. PubMed ID: 25698060
[TBL] [Abstract][Full Text] [Related]
70. Immunohistochemical detection of promyelocytic leukemia zinc finger and histone 1.5 in uterine leiomyosarcoma and leiomyoma.
Momeni M; Kalir T; Farag S; Kinoshita Y; Roman TY; Chuang L; Fishman DA; Burstein DE
Reprod Sci; 2014 Sep; 21(9):1171-6. PubMed ID: 24784718
[TBL] [Abstract][Full Text] [Related]
71. Microallelotyping defines novel regions of loss of heterozygosity in uterine leiomyomas.
Canevari Rde A; Pontes A; Rogatto SR
Mol Carcinog; 2005 Mar; 42(3):177-82. PubMed ID: 15605361
[TBL] [Abstract][Full Text] [Related]
72. Symplastic leiomyomas of the scrotum: a comparative study to usual leiomyomas and leiomyosarcomas.
Matoso A; Chen S; Plaza JA; Osunkoya AO; Epstein JI
Am J Surg Pathol; 2014 Oct; 38(10):1410-7. PubMed ID: 24832157
[TBL] [Abstract][Full Text] [Related]
73. MED12 and uterine smooth muscle oncogenesis: State of the art and perspectives.
Croce S; Chibon F
Eur J Cancer; 2015 Aug; 51(12):1603-10. PubMed ID: 26037152
[TBL] [Abstract][Full Text] [Related]
74. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C
Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677
[TBL] [Abstract][Full Text] [Related]
75. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
[TBL] [Abstract][Full Text] [Related]
76. Deletion of HMG17 in uterine leiomyomas with ring chromosome 1.
Polito P; Dal Cin P; Kazmierczak B; Rogalla P; Bullerdiek J; Van den Berghe H
Cancer Genet Cytogenet; 1999 Jan; 108(2):107-9. PubMed ID: 9973936
[TBL] [Abstract][Full Text] [Related]
77. Different karyotypic abnormalities, t(1;6) and del(7), in two uterine leiomyomas from the same patient.
Nilbert M; Heim S; Mandahl N; Flodérus UM; Willén H; Mitelman F
Cancer Genet Cytogenet; 1989 Oct; 42(1):51-3. PubMed ID: 2790746
[TBL] [Abstract][Full Text] [Related]
78. Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer.
Kämpjärvi K; Mäkinen N; Kilpivaara O; Arola J; Heinonen HR; Böhm J; Abdel-Wahab O; Lehtonen HJ; Pelttari LM; Mehine M; Schrewe H; Nevanlinna H; Levine RL; Hokland P; Böhling T; Mecklin JP; Bützow R; Aaltonen LA; Vahteristo P
Br J Cancer; 2012 Nov; 107(10):1761-5. PubMed ID: 23132392
[TBL] [Abstract][Full Text] [Related]
79. Inherited susceptibility to uterine leiomyomas and renal cell cancer.
Launonen V; Vierimaa O; Kiuru M; Isola J; Roth S; Pukkala E; Sistonen P; Herva R; Aaltonen LA
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3387-92. PubMed ID: 11248088
[TBL] [Abstract][Full Text] [Related]
80. Genomics of uterine leiomyomas: insights from high-throughput sequencing.
Mehine M; Mäkinen N; Heinonen HR; Aaltonen LA; Vahteristo P
Fertil Steril; 2014 Sep; 102(3):621-9. PubMed ID: 25106763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
